Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases.
Purity:
99.0%
CAS Number:
[1584645-37-3]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted